Featured Research

from universities, journals, and other organizations

Combination drug treatment can cut malaria by 30 percent

Date:
April 2, 2012
Source:
Walter and Eliza Hall Institute
Summary:
Malaria infections among infants can be cut by up to 30 percent when antimalarial drugs are given intermittently over a 12-month period, a three-year clinical trial in Papua New Guinea has shown.

Malaria infections among infants can be cut by up to 30 per cent when antimalarial drugs are given intermittently over a 12 month period, a three-year clinical trial in Papua New Guinea has shown.

Related Articles


The trial showed the drug regime was effective against both Plasmodium falciparum and Plasmodium vivax malaria, the first time antimalarial drugs have been shown to prevent infections by both species of malaria. The treatment regime, called intermittent preventive treatment (IPT), protected the infants against malaria for at least six weeks after the end of treatment, showing that it had an ongoing protective effect and did not hinder the development of natural immunity.

The study was led by Professor Ivo Mueller from the Walter and Eliza Hall Institute and Barcelona Centre for International Health Research (CRESIB) with Dr Patricia Rarau and Dr Nicolas Senn from the Papua New Guinea Institute of Medical Research (PNGIMR). Professor Peter Siba from PNGIMR, Associate Professor Louis Schofield from the Walter and Eliza Hall Institute, Professor John Reeder and Dr James Beeson from the Burnet Institute and Professor Stephen Rogerson from the University of Melbourne also collaborated on the project.

Professor Mueller, from the Walter and Eliza Hall Institute's Infection and Immunity division, said the findings could lead to trials of IPT in other regions, including South-East Asia and South America, where malaria, particularly P.vivax, is a major health problem. IPT has been used for number of years in sub-Saharan Africa, where more than 80 per cent of all deaths from malaria are in children under the age of five.

"Plasmodium vivax is the main cause of clinical malaria in infants outside of Africa," Professor Mueller said. "What this study has shown is that IPT can be useful in regions other than sub-Saharan Africa, that it can be an effective tool against P.vivax, and reaffirms that we need to effectively tailor preventive drugs to different malaria species in different regions."

IPT uses sporadic, short courses of combined antimalarial drugs to provide protection against malaria infection. "IPT is a cheap and easy way to decrease the burden of malaria in those most susceptible to clinical illness, such as young infants and pregnant women," Professor Mueller said.

As part of the clinical trial, infants aged three to 15 months were treated with a long-lasting antimalarial drug combination at three, six, nine and 12 months. Professor Mueller said the most effective drug combination in the trial was the long-lasting antimalarials sulfadoxine/pyrimethamine and amodiaquine (SP-AQ), which act against the two most lethal species of malaria parasite, Plasmodium falciparum and Plasmodium vivax. In the trial, SP-AQ treatment decreased infant infections by 35 per cent for Plasmodium falciparum and 23 per cent for Plasmodium vivax.

"These are quite remarkable figures," Professor Mueller said. "Different treatment strategies are required for different regions, depending on the dynamics of disease. The drug combination that was most effective in PNG was very different to the drugs you would use to treat malaria in Africa and also different to the drugs currently recommended for treating malaria in PNG."

Professor Peter Siba, director of PNGIMR, said a key factor in the effectiveness of the treatment was running it in parallel with existing vaccination and healthcare programs.

"In the trials, IPT was given at the same time as regular vaccinations and check-ups, using existing health care frameworks to deliver the treatment, so we saw a much higher adherence than with continuous treatment regimes. IPT is also preferable to long-term, continued use of antimalarial drugs, as it allows some natural immunity to develop while decreasing the number and severity of malaria infections," Professor Siba said.

This study was supported by a grant from the Bill & Melinda Gates Foundation.


Story Source:

The above story is based on materials provided by Walter and Eliza Hall Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Nicolas Senn, Patricia Rarau, Danielle I. Stanisic, Leanne Robinson, Cιline Barnadas, Doris Manong, Mary Salib, Jonah Iga, Nandao Tarongka, Serej Ley, Anna Rosanas-Urgell, John J. Aponte, Peter A. Zimmerman, James G. Beeson, Louis Schofield, Peter Siba, Stephen J. Rogerson, John C. Reeder, Ivo Mueller. Intermittent Preventive Treatment for Malaria in Papua New Guinean Infants Exposed to Plasmodium falciparum and P. vivax: A Randomized Controlled Trial. PLoS Medicine, 2012; 9 (3): e1001195 DOI: 10.1371/journal.pmed.1001195

Cite This Page:

Walter and Eliza Hall Institute. "Combination drug treatment can cut malaria by 30 percent." ScienceDaily. ScienceDaily, 2 April 2012. <www.sciencedaily.com/releases/2012/04/120402112927.htm>.
Walter and Eliza Hall Institute. (2012, April 2). Combination drug treatment can cut malaria by 30 percent. ScienceDaily. Retrieved November 23, 2014 from www.sciencedaily.com/releases/2012/04/120402112927.htm
Walter and Eliza Hall Institute. "Combination drug treatment can cut malaria by 30 percent." ScienceDaily. www.sciencedaily.com/releases/2012/04/120402112927.htm (accessed November 23, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, November 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

Ebola-Hit Sierra Leone's Late Cocoa Leaves Bitter Taste

AFP (Nov. 23, 2014) — The arable district of Kenema in Sierra Leone -- at the centre of the Ebola outbreak in May -- has been under quarantine for three months as the cocoa harvest comes in. Duration: 01:32 Video provided by AFP
Powered by NewsLook.com
Don't Fall For Flu Shot Myths

Don't Fall For Flu Shot Myths

Newsy (Nov. 23, 2014) — Misconceptions abound when it comes to your annual flu shot. Medical experts say most people older than 6 months should get the shot. Video provided by Newsy
Powered by NewsLook.com
WFP: Ebola Risks Heightened Among Women Throughout Africa

WFP: Ebola Risks Heightened Among Women Throughout Africa

AFP (Nov. 21, 2014) — Having children has always been a frightening prospect in Sierra Leone, the world's most dangerous place to give birth, but Ebola has presented an alarming new threat for expectant mothers. Duration: 00:37 Video provided by AFP
Powered by NewsLook.com
Could Your Genes Be The Reason You're Single?

Could Your Genes Be The Reason You're Single?

Newsy (Nov. 21, 2014) — Researchers in Beijing discovered a gene called 5-HTA1, and carriers are reportedly 20 percent more likely to be single. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins